GxP-CC

GxP-CC is a compliance consulting firm founded in 2013 that specializes in helping pharmaceutical and health sciences companies navigate complex regulatory requirements. The company provides services across the product lifecycle, from research and development through manufacturing, commercialization, and distribution.

The firm's core offerings include data integrity consulting, computer system validation, digital compliance and protection, quality compliance, hybrid project management, and AI/ML compliance services. Their team comprises scientists, pharmacists, engineers, and IT professionals who are fluent in over 15 languages and operate across 28 countries. GxP-CC takes a risk-based approach to compliance, focusing on systemizing processes and upskilling client staff to ensure sustainable regulatory adherence.

The company reports achieving significant efficiency improvements for clients, including an 82% reduction in speed to market, 81% increase in hiring and training speed, and projects that are 2.5 times more likely to stay on budget and schedule. GxP-CC has completed over 500 projects globally and maintains active thought leadership on evolving EU GMP regulations, particularly around Annexes 11, 22, and Chapter 4.

Organizations should consider GxP-CC when they need compliance expertise that combines regulatory knowledge with practical implementation experience in pharmaceutical environments. The firm's small, nimble structure allows for customized solutions while their 500+ project track record demonstrates capability at scale.

Expect a collaborative engagement model focused on knowledge transfer and staff upskilling rather than pure outsourcing. The firm's emphasis on sustainable compliance means they work to build internal capabilities alongside delivering project outcomes, which can reduce long-term dependency on external consultants.

GxP-CC operates exclusively within the pharmaceutical and life sciences sector, focusing on compliance requirements specific to drug development, manufacturing, and distribution. Their healthcare expertise centers on GxP regulations (Good Manufacturing Practices, Good Clinical Practices, Good Laboratory Practices) that govern pharmaceutical product quality and safety.

The firm addresses critical pharmaceutical compliance challenges including data integrity in clinical trials, computer system validation for manufacturing systems, pharmacovigilance data management, and quality compliance across the product lifecycle. Their recent focus on AI/ML compliance and EU GMP Annex 22 positions them at the forefront of emerging regulatory requirements for pharmaceutical digitalization.

The ideal client is a pharmaceutical or biotechnology company with global operations that requires specialized compliance support for computerized systems, data integrity, or quality processes. Organizations implementing new technologies like AI/ML in regulated environments, preparing for regulatory inspections, or modernizing validation approaches will find the firm's expertise particularly valuable. Companies that value knowledge transfer and building internal compliance capabilities rather than pure outsourcing will align well with GxP-CC's approach.